Gedelcan
Farmacogenómica del Cáncer - Pharmacogenomic of cancer
Date of inception 01 November 2019
Leader: Luis Alberto González Guijarro
Department: Biología de Sistemas
PhD program: Señalización Celular
Researchers
Classifications
- Group Recognition: Evaluación 2020 (02-06-2021) - Alto Rendimiento que mantiene la categoría, Evaluación 2021 (10-05-2022) - Alto Rendimiento que mantiene la categoría, Evaluación 2022 (23-06-2023) - Alto Rendimiento que mantiene la categoría, Evaluación 2025 (07-07-2026) - Alto Rendimiento que mantiene la categoría , Evaluación 2024 (10-06-2025) - Alto Rendimiento que mantiene la categoría
- Application Area: Ciencias de la Salud
- UNESCO Area: GENÉTICA BIOQUÍMICA, ONCOLOGÍA (VER 3207.03 Y 3207.13)
beta
Prevailing specialties (top 4)
Obtained from publications help
Obtained from publications
The displayed thematic specialties have been obtained through the application of artificial intelligence models, derived as a result of the Hercules Project from those publications with an abstract, provided that the record does not come from commercial databases, which impose restrictions on data usage.
The displayed thematic specialties have been obtained through the application of artificial intelligence models, derived as a result of the Hercules Project from those publications with an abstract, provided that the record does not come from commercial databases, which impose restrictions on data usage.
Former members (2)
- Ruiz Llorente, Lidia 20202025
- Toledo Lobo, María del Val 20192024